Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
oncology
nuclear transport inhibitors |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
Michael Kauffman
Sharon Shacham |
| gptkbp:headquartersLocation |
gptkb:Newton,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Karyopharm Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
selinexor
|
| gptkbp:numberOfEmployees |
200+
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
KPTI
|
| gptkbp:website |
https://www.karyopharm.com/
|
| gptkbp:bfsParent |
gptkb:Antengene
gptkb:Ropes_&_Gray_LLP |
| gptkbp:bfsLayer |
7
|